Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Gross Margin of 55.52% in Q4 2025, little changed quarter-over-quarter from 55.3% in Q3 2025, and up 5.0% on a YoY basis from 52.88% in Q4 2024.
Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Gross Margin history runs 16 years deep, the most recent figure standing at 55.52% for Q4 2025.
- In Q4 2025, Gross Margin rose 5.0% year-over-year to 55.52%; the TTM figure through Dec 2025 stood at 56.12% (up 100.0% YoY), while the FY2025 annual figure was 55.76%, up 28.0% from the prior year.
- Gross Margin was 55.52% for Q4 2025 at Prestige Consumer Healthcare, roughly flat from 55.3% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 59.07% in Q2 2021 to a low of 53.79% in Q1 2023.
- Historically, Gross Margin has averaged 55.99% across 5 years, with a median of 55.71% in 2022.
- The sharpest annual moves came in 2023 and 2025: Gross Margin slumped 242 bps in 2023, then surged 253 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 56.49% in 2021, then fell by 3 bps to 54.59% in 2022, then rose by 2 bps to 55.86% in 2023, then dropped by 1 bps to 55.47% in 2024, then climbed by 0 bps to 55.52% in 2025.
- The last three Gross Margin figures came in at 55.52% (Q4 2025), 55.3% (Q3 2025), and 56.24% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 55.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.52% |
| Sep 30, 2025 | 55.30% |
| Jun 30, 2025 | 56.24% |
| Mar 31, 2025 | 57.34% |
| Dec 31, 2024 | 55.47% |
| Sep 30, 2024 | 55.46% |
| Jun 30, 2024 | 54.66% |
| Mar 31, 2024 | 54.81% |
| Dec 31, 2023 | 55.86% |
| Sep 30, 2023 | 55.89% |
| Jun 30, 2023 | 55.38% |
| Mar 31, 2023 | 53.79% |
| Dec 31, 2022 | 54.59% |
| Sep 30, 2022 | 55.66% |
| Jun 30, 2022 | 57.79% |
| Mar 31, 2022 | 55.77% |
| Dec 31, 2021 | 56.49% |
| Sep 30, 2021 | 57.10% |
| Jun 30, 2021 | 59.07% |
| Mar 31, 2021 | 57.64% |